STAT3 staining intensities in all samples (initial negative biopsies, cancer positive cores, and other negative cores from the same batch biopsies) of cancer patients was significantly higher than that of benign patients (p<0.001), with a high sensitivity (80.8%) and specificity (76.3%). The gene discussed is STAT3; the disease is cancer.